The Patent Finder

Tesaro, Inc.

Also on record
Records under this name other than the patents Tesaro, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 17 patents it holds.

Back to Tesaro, Inc.

PatentTitleStatus Expires Confidence
US 11,091,459Niraparib Compositions
In force
 · High confidence
In forceHigh confidence
US 11,673,877Niraparib Compositions
In force
 · High confidence
In forceHigh confidence
14/357,884Modulating Certain Tyrosine Kinases
Abandoned
Abandoned Mar 16, 2016
AbandonedAbandoned Mar 16, 2016
14/962,588Methods and Materials for Predicting Response to Niraparib
Abandoned
Abandoned Sep 11, 2018
AbandonedAbandoned Sep 11, 2018
16/346,463Antibodies Directed Against T Cell Immunoglobulin and Mucin Protein 3 (TIM-3)
Abandoned
Abandoned Dec 20, 2021
AbandonedAbandoned Dec 20, 2021
16/584,149Niraparib Formulations
Abandoned
Abandoned Nov 24, 2020
AbandonedAbandoned Nov 24, 2020
16/608,111Antibody Agents Directed Against Lymphocyte Activation GENE-3 (LAG-3) and Uses Thereof
now held by Anaptysbio, Inc.
Abandoned
Abandoned Apr 6, 2023
AbandonedAbandoned Apr 6, 2023
16/958,646Methods of Treating Cancer
Abandoned
Abandoned Nov 29, 2024
AbandonedAbandoned Nov 29, 2024
16/967,351Pediatric Niraparib Formulations and Pediatric Treatment Methods
Abandoned
Abandoned Mar 22, 2024
AbandonedAbandoned Mar 22, 2024
17/073,198Niraparib Formulations
Abandoned
Abandoned Jan 28, 2023
AbandonedAbandoned Jan 28, 2023
10 of 34 records shown.
Pro members see all 34.
Pro members: see all 34 records
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited